Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0035 | 1 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |